Zinc as a plausible epigenetic modulator of glioblastoma multiforme.

作者: Vignesh Balaji E , Nitesh Kumar , Sairaj Satarker , Madhavan Nampoothiri

DOI: 10.1016/J.EJPHAR.2020.173549

关键词: MedicineDNA methyltransferaseTumor suppressor geneEpigenetic therapyEpigeneticsDNA methylationGliomaHistoneCancer researchBrain tumor

摘要: Glioblastoma Multiforme (GBM) is an aggressive brain tumor (WHO grade 4 astrocytoma) with unknown causes and associated a reduced life expectancy. The available treatment options namely radiotherapy, surgery chemotherapy have failed to improve Out of the various therapeutic approaches, epigenetic therapy one most studied. Epigenetic involved in effective GBM by inhibiting DNA methyltransferase, histone deacetylation non-coding RNA. It also promotes expression suppressor gene suppression oncogene. Various targets are being studied implement proper regulation control effectively. Zinc micronutrients which considered maintain promoting folding, protecting genetic material from oxidative damage controlling enzyme activation regulation. Here, we discussing importance zinc regulating modifications assessing its role glioblastoma research. discussion highlights artificial intelligence using epigenetics for envisaging glioma progression, diagnosis management.

参考文章(149)
Xiaoling Weng, Hong Zhang, Junyi Ye, Mengyuan Kan, Fatao Liu, Ting Wang, Jiaying Deng, Yanfang Tan, Lin He, Yun Liu, Hypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancer Scientific Reports. ,vol. 5, pp. 10154- 10154 ,(2015) , 10.1038/SREP10154
Katarzyna Rolle, miRNA Multiplayers in glioma. From bench to bedside. Acta Biochimica Polonica. ,vol. 62, pp. 353- 365 ,(2015) , 10.18388/ABP.2015_1072
GIULIO CABRINI, ENRICA FABBRI, CRISTIANA LO NIGRO, MARIA CRISTINA DECHECCHI, ROBERTO GAMBARI, Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review) International Journal of Oncology. ,vol. 47, pp. 417- 428 ,(2015) , 10.3892/IJO.2015.3026
Taiho Kambe, Tokuji Tsuji, Ayako Hashimoto, Naoya Itsumura, The Physiological, Biochemical, and Molecular Roles of Zinc Transporters in Zinc Homeostasis and Metabolism. Physiological Reviews. ,vol. 95, pp. 749- 784 ,(2015) , 10.1152/PHYSREV.00035.2014
Cathy L. Barr, Frank B. Furnari, Timothy F. Cloughesy, William H. Yong, Timothy C. Gahman, Andrew K. Shiau, Webster K. Cavenee, Bing Ren, Paul S. Mischel, Feng Liu, Gary C. Hon, Genaro R. Villa, Kristen M. Turner, Shiro Ikegami, Huijun Yang, Zhen Ye, Bin Li, Samantha Kuan, Ah Young Lee, Ciro Zanca, Bowen Wei, Greg Lucey, David Jenkins, Wei Zhang, EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling Molecular Cell. ,vol. 60, pp. 307- 318 ,(2015) , 10.1016/J.MOLCEL.2015.09.002
Amandine Etcheverry, Marc Aubry, Marie de Tayrac, Elodie Vauleon, Rachel Boniface, Frederique Guenot, Stephan Saikali, Abderrahmane Hamlat, Laurent Riffaud, Philippe Menei, Veronique Quillien, Jean Mosser, DNA methylation in glioblastoma: impact on gene expression and clinical outcome BMC Genomics. ,vol. 11, pp. 701- 701 ,(2010) , 10.1186/1471-2164-11-701
Turid Hellevik, Iñigo Martinez-Zubiaurre, Radiotherapy and the Tumor Stroma: The Importance of Dose and Fractionation Frontiers in Oncology. ,vol. 4, pp. 1- 1 ,(2014) , 10.3389/FONC.2014.00001
Difei Wang, Paul Helquist, Olaf Wiest, Zinc Binding in HDAC Inhibitors: A DFT Study Journal of Organic Chemistry. ,vol. 72, pp. 5446- 5449 ,(2007) , 10.1021/JO070739S
Keisuke Katsushima, Yutaka Kondo, Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation. Frontiers in Genetics. ,vol. 5, pp. 14- 14 ,(2014) , 10.3389/FGENE.2014.00014
Diamantina Vasilatou, Sotirios G. Papageorgiou, George Dimitriadis, Vasiliki Pappa, Epigenetic alterations and microRNAs: New players in the pathogenesis of myelodysplastic syndromes Epigenetics. ,vol. 8, pp. 561- 570 ,(2013) , 10.4161/EPI.24897